ILLUMINA INC
For the period ended Mar 30, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 30, 2025 · Filed May 9, 2025
ILMN$214.91-2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended | ||
|---|---|---|
| March 30,2025 | March 31,2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $131 | $(126) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation expense | 52 | 59 |
| Amortization of intangible assets | 17 | 49 |
| Share-based compensation expense | 73 | 96 |
| Deferred income taxes | 16 | (24) |
| Net gains on strategic investments | (32) | (5) |
| Change in fair value of contingent consideration liabilities | (11) | 16 |
| Gain on Helix contingent value right | — | (3) |
| Property and equipment and right-of-use asset impairment | — | 32 |
| Other | (2) | 9 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 46 | 90 |
| Inventory | 10 | 4 |
| Prepaid expenses and other current assets | 6 | (23) |
| Operating lease right-of-use assets and liabilities, net | (8) | (7) |
| Other assets | (1) | (6) |
| Accounts payable | (15) | (37) |
| Accrued liabilities | (56) | (53) |
| Other long-term liabilities | 14 | 6 |
| Net cash provided by operating activities | 240 | 77 |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (32) | (36) |
| Purchases of strategic investments | (24) | (12) |
| Cash paid for intangible assets | (7) | — |
| Net cash used in investing activities | (63) | (48) |
| Cash flows from financing activities: | ||
| Common stock repurchases | (200) | — |
| Taxes paid related to net share settlement of equity awards | (22) | (1) |
| Proceeds from issuance of common stock | 27 | 36 |
| Net cash (used in) provided by financing activities | (195) | 35 |
| Effect of exchange rate changes on cash and cash equivalents | 4 | (4) |
| Net (decrease) increase in cash and cash equivalents | (14) | 60 |
| Cash and cash equivalents at beginning of period | 1,127 | 1,048 |
| Cash and cash equivalents at end of period | $1,113 | $1,108 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.